Why the study?
Does transfemoral pacemaker implantation provide safe and effective pacing in patients with inaccessible or suboptimal superior vena cava routes?
Does transfemoral pacemaker implantation provide safe and effective pacing in patients with inaccessible or suboptimal superior vena cava routes?
Transfemoral pacemaker implantation is a safe and effective alternative for patients in whom the standard superior vena cava route is inaccessible or suboptimal.
May support transfemoral pacing when superior vena cava access is limited; hypothesis-generating and requires prospective validation.
We describe transfemoral pacemaker implantation in three patients in whom pacing via the superior vena cava was not possible or suboptimal. The first was an 88-year-old man with superior vena cava obstruction presenting with fractured epicardial pacing leads. Recent pneumonia increased the risks of a general anesthetic. The second patient was a 57-year-old man who was intolerant of a pectorally sited pacemaker because of the thinness of his anterior chest wall. The third patient was a 69-year-old woman who presented with an infected eroding pectorally sited pacemaker. Scarring secondary to a previous pacemaker infection rendered the contralateral pectoral site inaccessible. Since the subclavian route was inaccessible (case 1) or suboptimal (case 2 and 3), we implanted transvenous pacemakers via the femoral route, which was safe, and effective, during a 6-month follow-up period.
No takes yet. Share an insight, caveat, or question.
Barakat et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: